Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics

Area of Science:

• Biomedical Engineering
• Immunology
• Materials Science

Background:

• Cancer treatment faces challenges due to disease heterogeneity, limiting traditional therapies like chemotherapy, radiotherapy, and surgery.
• Immunotherapy shows promise but is hampered by suboptimal clinical responses and autoimmune side effects.
• There is a need for innovative, minimally invasive strategies for targeted cancer treatment.

Purpose of the Study:

• To review recent advancements in engineering biomaterials with immunomodulating properties for cancer theranostics.
• To explore the design of versatile nanosystems for combined therapeutic, diagnostic, and imaging applications in cancer.
• To highlight the potential of nanomaterials in advancing immune-based cancer interventions.

Main Methods:

• Review of current literature on biomaterial engineering for cancer therapy.
• Analysis of nanoparticle functionalization for targeted drug delivery and immune response modulation.
• Discussion of preclinical and clinical trial data on nanomedicine for cancer.

Main Results:

• Tunable biomaterials can effectively co-deliver anticancer drugs and immunomodulators, overcoming limitations of conventional treatments.
• Engineered nanosystems offer synergistic, combinatorial, and targeted approaches for cancer theranostics.
• Functionalized nanoparticles show potential in delivering antitumor agents and enhancing immune responses.

Conclusions:

• Biomaterial-based nanosystems represent a promising frontier for minimally invasive, targeted cancer immunotherapy.
• Further development in biomaterial engineering could lead to more accessible and effective immunological interventions for cancer.
• Nanomaterials are advancing cancer theranostics and paving the way for improved clinical applications.